Obstetrical & Gynecological Survey最新文献

{"title":"One-Hour Oral Glucose Tolerance Test for the Postpartum Reclassification of Women With Hyperglycemia in Pregnancy.","authors":"Ravi Retnakaran, Chang Ye, Caroline K Kramer, Anthony J Hanley, Philip W Connelly, Mathew Sermer, Bernard Zinman","doi":"10.1097/01.ogx.0001176344.19278.76","DOIUrl":"https://doi.org/10.1097/01.ogx.0001176344.19278.76","url":null,"abstract":"<p><p>(Abstracted from Diabetes Care 2025;48:887-895) After delivery, women who experience hyperglycemia during pregnancy are recommended to undergo a 2-hour oral glucose tolerance test (OGTT) to reclassify their glycemic status and assess type 2 diabetes risk. This test has proven to be an effective predictor, but uptake rates are low at around 50%, likely due to limited availability of new mothers and uncertainty about which provider is responsible for ordering the test.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"743-745"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Postpartum Medicaid Use in Birthing Parents and Access to Financed Care.","authors":"Jonas J Swartz, Ashley Lawson Avis, M Kate Bundorf, Marisa Elena Domino","doi":"10.1097/OGX.0000000000001476","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001476","url":null,"abstract":"<p><p>(Abstracted from JAMA Health Forum 2025;6(6):e251630) Medicaid covers more than 40% of all births in the United States, but pregnancy-related physical and mental health coverage traditionally ends 60 days postpartum. Recognizing the limitations of this policy, the American Rescue Act of 2021 allowed states to extend coverage to 12 months after delivery-a change now adopted by all states except Arkansas.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"741-742"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term Antibiotics for Disturbed Bladder Microbiome Disorders.","authors":"Yasir Bukhari, Ryan Chow, Alexander Jie Xiang, Nucelio Lemos","doi":"10.1097/OGX.0000000000001471","DOIUrl":"10.1097/OGX.0000000000001471","url":null,"abstract":"<p><p>(Abstracted from Int Urogynecol J 2025;36(7):1373-1382) Studies focused on lower urinary tract symptoms (LUTSs) have been increasing in the last few decades, and these studies have shown a link between a range of LUTSs and the bladder microbiome. Each individual has a unique bladder microbiome, although the general species present are fairly consistent across individuals.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"753-755"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Screening for Syphilis Infection During Pregnancy: US Preventive Services Task Force Reaffirmation Recommendation Statement.","authors":"","doi":"10.1097/01.ogx.0001176348.68652.62","DOIUrl":"10.1097/01.ogx.0001176348.68652.62","url":null,"abstract":"<p><p>(Abstracted from JAMA 2025;333(22):2006-2012) The US Preventive Services Task Force (USPSTF) has reaffirmed its recommendation for universal screening for syphilis in asymptomatic, pregnant adolescent and adult women early in pregnancy or at the first available opportunity. Through a reaffirmation process that considered whether new evidence warranted a change to its 2018 recommendation, the USPSTF concluded with high certainty that the recommendation has a \"substantial net benefit.\"</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"747-749"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Active Treatment and Survival Trends for Periviable Births by Race and Ethnicity.","authors":"Nansi S Boghossian, Lucy T Greenberg, Erika M Edwards, Jeffrey D Horbar","doi":"10.1097/01.ogx.0001176336.07664.a1","DOIUrl":"https://doi.org/10.1097/01.ogx.0001176336.07664.a1","url":null,"abstract":"<p><p>(Abstracted from JAMA 2025;333(21):1925-1928) Restrictive abortion policies in many states may raise ethical and clinical considerations among neonatologists, who feel obligated to attempt life support to infants, regardless of the prognosis. Studies that have evaluated trends in initiating active treatment and the survival rate of infants born between 22 and 25 weeks of gestation are scarce.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"737-738"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Community-Based Mentoring to Reduce Maternal and Perinatal Mortality in Adolescent Pregnancies in Sierra Leone (2YoungLives): A Pilot Cluster-Randomized Controlled Trial.","authors":"Cristina Fernandez Turienzo, Lucy November, Mangenda Kamara, Osman Conteh, Philemon Kamara, Appiah M Kingsford, Peter J S Koroma, Michael Munu, Alexandra E Ridout, Betty Sam, Paul T Seed, Suzanne Thomas, Prince T Williams, Andrew H Shennan, Jane Sandall","doi":"10.1097/01.ogx.0001176340.24636.22","DOIUrl":"10.1097/01.ogx.0001176340.24636.22","url":null,"abstract":"<p><p>(Abstracted from Lancet 2025;405(10497):2302-2312) Sierra Leone has one of the highest maternal mortality rates in the world, with 443 deaths per 100,000 live births in 2020. Adolescent girls between 10 and 19 years old represent up to 40% of maternal deaths.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 12","pages":"738-740"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intrahepatic Cholestasis of Pregnancy: A Comparative Review of Guidelines.","authors":"Sonia Giouleka, Christiana Zafeirati, Antonios Siargkas, Georgios Michos, Sofoklis Stavros, Anastasios Potiris, Apostolos Mamopoulos, Ioannis Kalogiannidis, Themistoklis Dagklis, Ioannis Tsakiridis","doi":"10.1097/OGX.0000000000001438","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001438","url":null,"abstract":"<p><strong>Importance: </strong>Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disorder associated with significant maternal complications and increased neonatal morbidity and mortality.</p><p><strong>Objective: </strong>The aim of this study was to review and compare the most recently published influential guidelines on the diagnosis and management of ICP, highlighting the discrepancies in key areas.</p><p><strong>Evidence acquisition: </strong>A descriptive review of 6 national guidelines from the Society for Maternal-Fetal Medicine, the Royal College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynecologists of Canada, the Society of Obstetric Medicine of Australia and New Zealand, the Chinese Medical Association, and the Working Group on Obstetrics and Prenatal Medicine of Germany was conducted along with a comparison of their recommendations regarding this pregnancy complication.</p><p><strong>Results: </strong>There is an overall agreement among the reviewed guidelines regarding the definition and the diagnosis of ICP, although minor discrepancies exist with regard to the bile acid cutoff levels. They also highlight the importance of a detailed history and physical examination to exclude other potential causes of maternal pruritus and recommend the evaluation of liver function and the appropriate counseling on the associated maternal and neonatal complications following diagnosis. Ursodeoxycholic acid is recommended by all guidelines (except from the Royal College of Obstetricians and Gynecologists) as first-line treatment for symptoms relief. However, the recommendations regarding the classification of ICP, the frequency of bile acid monitoring, the necessity of fetal surveillance, and the optimal timing of delivery are inconsistent.</p><p><strong>Conclusions: </strong>Obstetrics cholestasis is a severely pruritic form of reversible cholestasis of unknown pathophysiology that is associated with significant fetal risks and no definitive treatment. The variations among the existing guidelines reflect the heterogeneity of available evidence, while highlighting the necessity for further research.</p><p><strong>Target audience: </strong>Obstetricians and gynecologists, family physicians.</p><p><strong>Learning objectives: </strong>After participating in this activity, the learner should be better able to explain the process of differential diagnosis when ICP is suspected; identify the ICP-associated fetal and maternal risks on which affected individuals should be counseled; and describe the medical treatment options and the optimal timing of delivery.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"717-730"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perinatal Outcomes Following Nonadherence to Guideline-Based Screening for Gestational Diabetes: A Population-Based Cohort Study.","authors":"Elizabeth Nethery, Kelly Pickerill, Luba Butska, Michelle Turner, Jennifer A Hutcheon, Patricia A Janssen, Laura Schummers","doi":"10.1097/01.ogx.0001172280.42312.99","DOIUrl":"https://doi.org/10.1097/01.ogx.0001172280.42312.99","url":null,"abstract":"<p><p>(Abstracted from Acta Obstet Gynecol Scand 2025;104:839-849) Gestational diabetes mellitus (GDM), defined as high blood sugar onset in pregnancy, is associated with adverse outcomes and increased long-term maternal diabetes risk. Screening protocols vary internationally, with some countries testing only high-risk pregnancies, but Canada has recommended universal screening since 2003.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"683-685"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of Insulin Resistance With In Vitro Fertilization Outcomes in Women Without Polycystic Ovarian Syndrome: Potential Improvement With Metformin Treatment.","authors":"Ana Belén Albert, Ana Corachán, Elena Juárez-Barber, Mauro Cozzolino, Antonio Pellicer, Diana Alecsandru, Irene Cervelló, Hortensia Ferrero","doi":"10.1097/01.ogx.0001172308.31828.d0","DOIUrl":"10.1097/01.ogx.0001172308.31828.d0","url":null,"abstract":"<p><p>(Abstracted from Hum Reprod 2025;40(8):1562-1569) Successful pregnancy depends on many factors, including metabolic processes. Glucose fluctuation may hinder embryo development and/or implantation, but glucose is necessary to prepare the endometrium for successful implantation by producing glycogen.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"706-707"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.","authors":"Claire Booth, Julián Sevilla, Elena Almarza, Caroline Y Kuo, Josune Zubicaray, Dayna Terrazas, Gráinne O'Toole, Maria Chitty-Lopez, Grace Choi, Eileen Nicoletti, Janel Long-Boyle, Augustine Fernandes, Kritika Chetty, Satiro De Oliveira, Crystal Banuelos, Jinhua Xu-Bayford, Antonella Lucía Bastone, Philipp John-Neek, Connie Jackson, Theodore B Moore, Kimberly Gilmour, Axel Schambach, Michael Rothe, Sanchali Kasbekar, Gayatri R Rao, Kinnari Patel, Gaurav Shah, Adrian J Thrasher, Juan A Bueren, Jonathan D Schwartz, Donald B Kohn","doi":"10.1097/OGX.0000000000001462","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001462","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;392:1698-1709) Leukocyte adhesion deficiency type I (LAD-I) is an autosomal recessive immune disorder marked by recurrent, life-threatening infections, with 25% to 39% mortality before age 2 years without curative therapy. Common symptoms include umbilical-cord complications, poorly healing cutaneous lesions, persistent leukocytosis, and periodontitis.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"687-689"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}